Federal Cannabis Legalization and Social Equity

Quarterly Insights from the RAND Drug Policy Research Center | View in browser

Join RAND on Facebook Follow RAND on Twitter

Quarterly insights from the RAND Drug Policy Research Center

July 2021

Cannabis leaf, photo by underworld/Adobe Stock

Federal Cannabis Legalization &
Social Equity

This article describes some of the opportunities as well as some puzzles and trade-offs surrounding the use of cannabis policy to advance social equity. If the federal government decides to legalize cannabis, this could have major implications for social equity efforts. Read more »

Raw opium from a poppy head is seen at a farmer's field on the outskirts of Jalalabad, Afghanistan, April 28, 2015, photo by Parwiz/Reuters

Photo by Parwiz/Reuters

Afghanistan in the Era of Fentanyl: Considering Potential Economic and Political Impacts of a Collapse in Demand for Afghanistan’s Opiates

Fentanyl and other synthetic opioids are displacing heroin in some major drug markets. What might happen to Afghanistan—the world’s largest producer of illegal opium poppy—if demand for its opiates dropped off sharply and permanently?

Read more »

Tablets of Hydrocodone at a pharmacy in Portsmouth, Ohio, June 21, 2017, photo by Bryan Woolston/Reuters

Photo by Bryan Woolston/Reuters

State-Level Opioid Policy Analyses: Moving Beyond the Classic Difference-in-Differences Model

These videos provide an overview of key methodological challenges faced when evaluating the effectiveness of state-level opioid policies using annual state-level data, as well as potential solutions and practice guidelines.

View the Presentation »

Close up of a police car at a nighttime traffic stop, photo by RichLegg/Getty Images

Photo by RichLegg/Getty Images

Can Novel 'Swift-Certain-Fair' Programs Work Outside of Pioneering Jurisdictions?

South Dakota's 24/7 Sobriety Program requires individuals charged or convicted of alcohol-involved offenses to avoid alcohol and submit to frequent testing. This successful program appears to be making a difference in Montana as well.

Read more »

Female psychiatrist listening to her patient and taking notes, photo by CasarsaGuru/Getty Images

Photo by WoodysPhotos/Getty Images

Medication Management of Co-Occurring Opioid Use Disorder in Mental Health Settings: A Guide for Practitioners

Psychiatrists, nurse practitioners, and other clinicians who work in mental health settings are in an optimal position to treat co-occurring opioid use and mental health disorders (COD-opioid). This guide prepares mental health practitioners to identify clients with COD-opioid and find appropriate treatment.

Read more »

Trending Research

How Criminal System Racial Disparities May Translate Into Health Disparities

Contingent Reinforcement of Group Participation Versus Abstinence in a Methadone Maintenance Program

DPRC in the News

Overdoses Involving Cocaine and Fentanyl Are On The Rise

NPR

Experts: Spend Opioid Settlement Funds on Fighting Opioids

ABC News

Five Myths About Marijuana

Washington Post

Contact

Beau Kilmer

Beau Kilmer

Director, RAND Drug Policy Research Center

McCauley Chair in Drug Policy Innovation, RAND